DANGEROUS AND UNDESIRABLE DRUG INTERACTIONS OF STATINS IN PATIENTS WITH CARDIOVASCULAR DISEASE
Relevance. Antihypercholesterolemic drugs fr om the group of statins have a significant impact on the metabolism of the human body. Consideration of pharmacokinetic features of statins and drug interaction with drugs of this group is an important aspect of their safe use. Drugs administered simultaneously with statins may be inducers or inhibitors (substrates) of CYP3A4/A5 cytochrome P450 liver isoenzymes, which should be considered in daily clinical practice in the management of this category of patients
The aim was to study the frequency and structure of the appointment of unwanted combinations of statins with other drugs in Semey.
Materials and methods. Design: cross-sectional study. The study included 2790 outpatient records of patients with diagnosis: Coronary heart disease with concomitant hypercholesterolemia. The frequency of simultaneous administration of statins with other drugs was analyzed. We took into account the peculiarities of their interaction at the level of metabolism of cytochrome P450 CYP3 isoenzymes AND transport systems of proteins-transporters of P-glycoprotein and OATR1B and to identify potentially dangerous and significant drug combinations.
Methods of descriptive statistics are used. Numerical analysis of statistical significance was not carried out due to lack of necessity.
Research result. Our study revealed the presence of undesirable and dangerous combinations in the majority of patients receiving statin therapy (63.7%). The frequency of very dangerous combinations in the study was relatively low (7 cases, 0.25%). In 72.5% of cases, we did not find safety monitoring in cases wh ere it is recommended to take statins with caution and under the control of biochemical and other indicators.
Conclusion. We have determined a fairly high frequency of the appointment of undesirable combinations of statins with other drugs that have competitive metabolism at the level of CYP3A, OATP1B1 and P-glycoprotein in absolute terms and compared with the data of studies conducted in developed countries.
Number of Views: 418
Category of articles:
Original articles
Bibliography link
Махатова А.Р., Тулеутаева Р.Е. Опасные и нежелательные межлекарственные взаимодействия статинов у больных кардиоваскулярной патологии // Наука и Здравоохранение. 2019. 2 (Т.21).С. 55-66. Makhatova A.R., Tuleutaeva R.E. Dangerous and undesirable drug interactions of statins in patients with cardiovascular disease // Nauka i Zdravookhranenie [Science & Healthcare]. 2019, (Vol.21) 2, pp. 55-66. Махатова Ә.Р., Тулеутаева Р.Е. Кардиоваскулярлы жүйенің патологиясы бар науқастарда статиндердің қауіпті және жағымсыз дәрі-дәрмектік өзара әрекеттесуі // Ғылым және Денсаулық сақтау. 2019. 2 (Т.21). Б. 55-66.Related publications:
VALIDATION OF THE KAZAKH VERSION OF THE DEPRESSION ANXIETY STRESS SCALE (DASS-21) IN MEDICAL FACULTY STAFF SAMPLE: THE PILOT STUDY
PREDICTIVE VALUE OF PSYCHOMETRIC TESTING IN CONTEXT OF CREATING ADAPTIVE ENVIRONMENT FOR HIGHER MEDICAL EDUCATION
ASSESSMENT OF STUDENTS' AWARENESS ABOUT THE HARMS OF MICROPLASTICS ON THE HUMAN BODY
THE IMPACT OF COMPLAINTS ON QUALITY OF LIFE, PSYCHOLOGICAL WELL-BEING AND HEALTH OF MEDICAL WORKERS
DEVELOPMENT AND VALIDATION OF A QUESTIONNAIRE FOR PATIENTS "STUDYING THE OPINION OF PATIENTS' SATISFACTION WITH NURSE INDEPENDENT APPOINTMENT AT THE LEVEL OF PRIMARY HEALTH CARE"